Compare IT & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IT | ICLR |
|---|---|---|
| Founded | 1979 | 1990 |
| Country | United States | Ireland |
| Employees | 40 | N/A |
| Industry | Other Consumer Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8B | 9.3B |
| IPO Year | 2010 | 2001 |
| Metric | IT | ICLR |
|---|---|---|
| Price | $127.49 | $146.00 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 13 |
| Target Price | ★ $189.25 | $178.62 |
| AVG Volume (30 Days) | ★ 1.2M | 1.1M |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.18 | N/A |
| Revenue | ★ $2,021,441,000.00 | N/A |
| Revenue This Year | $3.52 | N/A |
| Revenue Next Year | $5.08 | N/A |
| P/E Ratio | $39.87 | ★ $12.91 |
| Revenue Growth | ★ 13.30 | N/A |
| 52 Week Low | $126.44 | $66.57 |
| 52 Week High | $409.76 | $211.00 |
| Indicator | IT | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 27.02 | 60.83 |
| Support Level | N/A | $99.11 |
| Resistance Level | $162.80 | $193.87 |
| Average True Range (ATR) | 7.87 | 6.94 |
| MACD | -3.87 | -0.69 |
| Stochastic Oscillator | 2.43 | 57.21 |
Gartner Inc delivers actionable, objective business and technology insights that drive smarter decisions and stronger performance on an organization's mission-critical priorities. It delivers its products and services globally through three reportable segments - Business and Technology Insights, Conferences and Consulting. Insights equips executives and their teams from every Majority function, geography, industry and sector with actionable, objective insights, guidance and tools. Conferences provides executives and teams across an organization the opportunity to learn, share and network. and Consulting serves senior executives technology-driven strategic initiatives leveraging the power of Gartner's actionable, objective insight. The Majority revenue is derived from the Insights segment.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.